Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss is a common but often unreported side effect of cancer treatments, especially for breast and prostate cancers.

Hair loss is a common side effect of hormone treatments for cancer.

Women with pituitary adenomas often have reproductive issues, like irregular periods and trouble getting pregnant, but not always breast milk production without pregnancy.

In 2009, there were new medical devices, treatments for gynecological conditions, updated health guidelines, and legal developments in women's health.

The document listed medical job ads and guidelines for breast cancer screening.

Dermatological conditions are complex and treatments often have mixed results.

There's no significant link between blood fat levels and male pattern baldness.

Men with early hair loss may have higher insulin resistance and should be checked for related health issues.

Orphan drug benefit scores in Germany are influenced by phase III data and lack of alternatives, but not linked to price or discounts.

Measuring plasma testosterone glucosiduronate is a reliable way to detect high male hormone levels in women.

The InCISE score is a promising tool for assessing wound healing in head and neck surgery but needs more research for broader use.

Salivary testosterone is a better measure for hirsutism than serum testosterone.

Women with PCOS often have hirsutism and skin changes, which indicate a need for metabolic health checks.

Testosterone therapy can improve hormone levels and quality of life in men with morphine-induced hormone issues.

Patients with HR+/HER2- advanced breast cancer commonly experience fatigue, hair loss, and pain, which significantly affect daily activities.

Ovarian hyperthecosis can cause high testosterone and symptoms like hair loss, and surgery can help improve these symptoms.

Homoeopathy may help treat PCOS, but more research is needed.

Both dermatologists and patients in Japan agree that treatment success for alopecia areata is having 20% or less scalp hair loss.

Using GnRHa agonists helps diagnose and treat ovarian hyperthecosis when surgery isn't possible.

A change in SALT scores of 42 or 43 indicates meaningful improvement in alopecia areata treatment.

Homeopathy helped a 22-year-old woman with PCOS have regular periods.

The models accurately predicted urticaria in Ukrainian women but struggled to differentiate between mild and severe cases based on body structure.

Hyperandrogenism did not affect sexual function in young women.

Phosphorus homeopathy treatment led to complete hair regrowth in two Alopecia Areata patients.

The VQ-Dermato is a reliable French questionnaire for measuring quality of life in chronic skin disorder patients.

The study aims to create a model to predict health attributes using diverse health data from Japanese adults.

Spironolactone helps reduce pain and lesions in hidradenitis suppurativa patients, and lower doses are also effective.

Women with irregular periods and/or excessive body hair are more likely to have polycystic ovaries, and this condition is linked to higher health risks.

The Hair Check tool can measure hair loss, but patients' own reports are more reliable for assessing hair loss during chemotherapy.

Skin problems in patients with polycystic ovarian disease are linked to body weight, blood sugar, and hormone levels.